In addition, an increase in dendritic cells was also observed in the peripheral blood of breast cancer patients, with higher levels in HER-2-positive breast cancer patients than in HER-2-negative patients, suggesting a difference between the various breast cancer subtypes. This evidence concerns the gene ERBB2 and breast carcinoma.